Genscript Biotech Stock Investor Sentiment

GNNSF Stock  USD 1.25  0.01  0.79%   
Roughly 62% of Genscript Biotech's investor base is looking to short. The analysis of overall sentiment of trading Genscript Biotech pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Genscript Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Genscript Biotech stock news signals to limit their universe of possible portfolio assets.
Genscript Biotech pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Genscript daily returns and investor perception about the current price of Genscript Biotech as well as its diversification or hedging effects on your existing portfolios.
  
few days ago at news.google.com         
Genscript Biotechs CARVYKTI Boosts Multiple Myeloma Results - MSN
Google News at Macroaxis
few days ago at news.google.com         
Genscript Biotechs CARVYKTI Boosts Multiple Myeloma Results - TipRanks
Google News at Macroaxis
over a week ago at news.google.com         
Genscript Biotech adds HK983m to market cap in the past 7 days, though investors from three years ag...
Google News at Macroaxis
over a week ago at news.google.com         
Genscript Biotech Announces CEO Resignation and Leadership Changes - MSN
Google News at Macroaxis
over three weeks ago at news.google.com         
Genscript Biotech Aligns Interests with Restricted Share Grant - TipRanks
Google News at Macroaxis
over three weeks ago at news.google.com         
Market Still Lacking Some Conviction On Genscript Biotech Corporation - Simply Wall St
Google News at Macroaxis
over three weeks ago at news.google.com         
GenScript Subsidiary ProBio Instrumental in Latest Fight Against Cancer - Morningstar
Google News at Macroaxis
over a month ago at news.google.com         
Genscript Biotech Strengthens Board with New Appointment - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Amid geopolitical tensions, Legend sheds GenScript as its majority shareholder - FiercePharma
Google News at Macroaxis
over two months ago at news.google.com         
Genscript Biotech Announces Subsidiarys AGM Date - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Shareholders in Genscript Biotech have lost 66, as stock drops 3.3 percent this past week - Simply W...
Google News at Macroaxis
over three months ago at news.google.com         
GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering...
Google News at Macroaxis
over three months ago at news.google.com         
Genscript Biotech Awards Shares to Employees - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Earnings call GenScript Biotech reports strong growth and robust pipeline By Investing.com - Investi...
Google News at Macroaxis
over three months ago at news.google.com         
Will Genscript cash out of Legend Biotech in the face of fat profit temptation - Bamboo Works
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Genscript Biotech that are available to investors today. That information is available publicly through Genscript media outlets and privately through word of mouth or via Genscript internal channels. However, regardless of the origin, that massive amount of Genscript data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Genscript Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Genscript Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Genscript Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Genscript Biotech alpha.

Genscript Biotech Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Genscript Pink Sheet analysis

When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stocks Directory
Find actively traded stocks across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.